Drug intelligence / Profile preview

magnesium chloride + potassium chloride + sodium chloride + sodium gluconate + sodium

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Small Molecules
Administration
Intravenous
01

Overview

This entry refers to an incompletely specified multi-electrolyte intravenous solution containing magnesium chloride, potassium chloride, sodium chloride, sodium gluconate, and a truncated sodium-containing component. In the provided context, the closest fully specified marketed products are balanced crystalloid solutions such as Plasma-Lyte 148, Plasma-Lyte A, and Normosol-R, which typically include sodium acetate in addition to the listed electrolytes. These products are sterile, isotonic **small-molecule electrolyte replacement solutions** administered intravenously to expand extracellular fluid volume and correct electrolyte depletion in settings such as surgery, trauma, burns, shock, and moderate blood loss. The therapeutic effect is produced by replacement of physiologic ions in the extracellular compartment rather than binding to a single discrete molecular target. Because the queried name ends with an incomplete \"sodium\" term and could map to more than one specific marketed formulation, the exact product identity cannot be assigned with confidence from the input alone.

Other names
magnesium chloride + potassium chloride + sodium chloride + sodium gluconate + sodium

Beyond the preview

Go deeper on magnesium chloride + potassium chloride + sodium chloride + sodium gluconate + sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium chloride + potassium chloride + sodium chloride + sodium gluconate + sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call